BNF:

3.3.3

Status:

Grey - after consultant/specialist initiation

Decision Date:

August 2017

Comments

GREY after Respiratory Consultant/Specialist initiation^: NICE TA461: (replaces TA244 - negative appraisal) Roflumilast for treating chronic obstructive pulmonary disease.

Patients care to be transferred to primary care after 3 months roflumilast treatment under the Respiratory Consultant/Specialist. Further information can be found in the COPD guidance. (Decision date  - August 2020)

Grey Drug Classifications

• 6: NICE guidance

search again